Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (201-210 of 388) with videos related to

Pageof 39
Sort By:
International Journal of Molecular Sciences|August 17, 2019
Understanding the Mechanisms of Resistance in <i>EGFR</i>-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment StrategyMarzia Del Re, Stefania Crucitta, Giulia Gianfilippo, et al.
Clinical Genitourinary Cancer|July 17, 2017
Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical TrialsNizar M Tannir, Robert A Figlin, Martin E Gore, et al.
Future Oncology (London, England)|November 7, 2015
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysisAnnalisa Guida, Cristina Masini, Michele Milella, et al.
Journal of Neuro-Oncology|October 30, 2022
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?Roberta Rudà, Francesco Bruno, Alessia Pellerino, et al.
European Urology|May 21, 2014
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancerLaurence Albiges, Toni Choueiri, Bernard Escudier, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.
Cancer|September 24, 2010
Sunitinib in metastatic renal cell carcinoma patients with brain metastasesMartin E Gore, Subramanian Hariharan, Camillo Porta, et al.
Archives of Internal Medicine|December 15, 2004
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparinsSergio Siragusa, Raffaela Anastasio, Camillo Porta, et al.
International Journal of Molecular Sciences|January 18, 2018
Telomeric Repeat-Containing RNAs (TERRA) Decrease in Squamous Cell Carcinoma of the Head and Neck Is Associated with Worsened Clinical OutcomeValerio Vitelli, Paolo Falvo, Solomon G Nergadze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2018
Opening an onconephrology clinic: recommendations and basic requirementsLaura Cosmai, Camillo Porta, Mark A Perazella, et al.
Pageof 39

Showing results (201-210 of 388) with videos related to

Sort By:
Pageof 39
International Journal of Molecular Sciences|August 17, 2019
Understanding the Mechanisms of Resistance in <i>EGFR</i>-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment StrategyMarzia Del Re, Stefania Crucitta, Giulia Gianfilippo, et al.
Clinical Genitourinary Cancer|July 17, 2017
Long-Term Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma: A Pooled Analysis of Clinical TrialsNizar M Tannir, Robert A Figlin, Martin E Gore, et al.
Future Oncology (London, England)|November 7, 2015
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysisAnnalisa Guida, Cristina Masini, Michele Milella, et al.
Journal of Neuro-Oncology|October 30, 2022
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?Roberta Rudà, Francesco Bruno, Alessia Pellerino, et al.
European Urology|May 21, 2014
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancerLaurence Albiges, Toni Choueiri, Bernard Escudier, et al.
Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.
Cancer|September 24, 2010
Sunitinib in metastatic renal cell carcinoma patients with brain metastasesMartin E Gore, Subramanian Hariharan, Camillo Porta, et al.
Archives of Internal Medicine|December 15, 2004
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparinsSergio Siragusa, Raffaela Anastasio, Camillo Porta, et al.
International Journal of Molecular Sciences|January 18, 2018
Telomeric Repeat-Containing RNAs (TERRA) Decrease in Squamous Cell Carcinoma of the Head and Neck Is Associated with Worsened Clinical OutcomeValerio Vitelli, Paolo Falvo, Solomon G Nergadze, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 9, 2018
Opening an onconephrology clinic: recommendations and basic requirementsLaura Cosmai, Camillo Porta, Mark A Perazella, et al.
Pageof 39